miércoles, 21 de septiembre de 2022

Guidance for Tecovirimat Use Under Expanded Access Investigational New Drug Protocol during 2022 U.S. Monkeypox Outbreak | Monkeypox | Poxvirus | CDC

Guidance for Tecovirimat Use Under Expanded Access Investigational New Drug Protocol during 2022 U.S. Monkeypox Outbreak | Monkeypox | Poxvirus | CDC

No hay comentarios: